IVD Market in Europe

Europe IVD Market Opportunity Analysis and Industry Forecast, 2016-2023

Global Opportunity Analysis and Industry Forecast, Global Opportunity Analysis and Industry Forecast, 2016-2023 2017-2023

Pages: 180 Tables: 69 Charts: 54

EUROPE IVD MARKET The Europe IVD Market is accounted for $19,124 million in 2016, and is estimated to reach $26,623 million by 2023, growing at a CAGR of 4.7% during the analysis period (2017-2022). IVD diagnostics involve non-invasive tests performed on biological samples such as, blood, urine, and tissues to detect the diseases. These tests are used for diagnosis, screening, and therapeutic monitoring of diseases. In addition, IVD tests is performed in laboratories, hospitals, and special tests such as, pregnancy tests and glucose monitoring that are performed at home.

Rise in incidence & prevalence of chronic disease, technological advancements in IVD technique, and rise in healthcare expenditure fuel the market growth during the analysis period. However, shortage of experienced healthcare professionals and lack of awareness among the population restrict the growth of the market.

In vitro diagnostic tests are performed using biological samples to detect the health ailments and other diseases. Rise in technological developments in IVD techniques, increase in incidence and prevalence of chronic and infectious diseases and increase in government healthcare expenditure in the European region drive the market growth. However, stringent government regulations related to the safety and efficacy of the IVD and unfavorable reimbursement policies are expected to restrain the market growth during the forecast period.

EUROPE IVD MARKET Increase in Prevalence of Chronic Diseases IVD market in the European countries is in trend due to increase in incidences of chronic diseases such as cancer, cardiovascular diseases, neurodegenerative disorder, and diabetes. Chronic disease is a leading cause of death in Europe, for instance, the incidence of chronic diseases is high in high-income countries. According to WHO, incidence, prevalence, severity and duration, and mortality for more than 130 major causes, which includes data since 2000 for WHO member countries and for sub-regions throughout the world (WHO 2008a, WHO 2008b; WHO 2009). Thus, high share of chronic diseases compared with communicable, maternal, perinatal and nutritional conditions, as well as injuries in low income, lower middle income, upper middle income, and high-income countries.

Rise in Geriatric Population The Europe IVD market is on an increase owing to rise in geriatric population as there is a rise in the number in volume of chronic diseases. For instance, the population of the EU-28 on January 1, 2016 was estimated at 510.3 million. Young people (0 to 14 years old) made up 15.6 % of the EU-28s population, while people considered to be of working age (15 to 64 years old) accounted for 65.3 % of the population. Older people (aged 65 or over) had a 19.2 % share (an increase of 0.3 % compared with the previous year and an increase of 2.4 % compared with 10 years earlier), which estimated that European countries accounted for highest aging population and size of aging population continues to lead during the forecast period.

EUROPE IVD MARKET

Technological Advancement in IVD In the past 50 years, IVD technologies were used only in clinical labs. Initially, pregnancy test was undertaken in laboratories; however, these days the tests are conducted at home by placing urine samples on test sticks. These offer accurate results, are less time consuming, and can be easily performed. Similarly, the blood glucose levels testing can be done using point-of-care testing devices such as glucometer. Similarly, the HIV test can also be conducted at home using a mouth swab that is inbuilt in the diagnosis device. It provides results in 2040 minutes. Previously, these tests were carried out in clinical laboratories where individual blood sample was taken.

Request Free Sample: https://www.alliedmarketresearch.com/request-sample/4352 Â

EUROPE IVD MARKET Key Benefits: • The study provides an in-depth analysis of the Europe IVD market with current trends and future estimations to elucidate the imminent investment pockets • The report provides a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on prevailing market opportunities • Extensive analysis by technology and application helps understand various trends and prevailing opportunities in the respective market • Comprehensive analysis of all countries is provided, which determines the main opportunities in these geographies • Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which predict the competitive outlook of the Europe IVD market

EUROPE IVD MARKET Based on product type, the reagents segment held the highest market share of third-fifths in 2016, due to introduction of efficacious reagents in the market that are utilized in IVD technology for the detection of several disease.

By Product Type • Reagents • Instruments • Software and Services Based on technique, the immunodiagnostics segment contributed the highest market share (one-third) in 2016, owing to the increase in prevalence of chronic diseases such as cancer that is analyzed by tissue or other diagnostic techniques and increase in demand for non-invasive techniques.

By Technique Type • Immunodiagnostics • Blood Testing • Molecular Diagnostics • Tissue Diagnostics • Clinical Chemistry • Other IVD Techniques

EUROPE IVD MARKET Based on application, the infectious diseases segment contributed the highest market share (twosevenths) in 2016, owing to the increase in prevalence of infectious diseases such as tuberculosis, malaria, and pertussis that fuel the IVD market.

By Application • • • • • • •

Infectious Diseases Cancer Cardiac Diseases Immune System Disorders Nephrological Diseases Gastrointestinal Diseases Other Indications

EUROPE IVD MARKET Based on end users, the standalone laboratory segment captured the highest market share (thirdsevenths) in 2016, mainly due to availability of complex tests that are difficult to perform and increase in healthcare expenditure thus improving healthcare facilities.

North America Europe Asia-Pacific LAMEA

EUROPE IVD MARKET Companies profiled in this market include • • • • • • • • • •

Thermo Fisher Scientific Inc., Alere Inc Biomerieux Danaher Corporation F. Hoffmann-La Roche AG Becton Dickinson and Company Bio-Rad Laboratories Bayer AG Sysmex Corporation Johnson & Johnson

Do Purchase Report: https://www.alliedmarketresearch.com/purchase-enquiry/4352

EUROPE IVD MARKET

Contact: Shriram Dighe 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free: +1-800-792-5285 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1⟨855⟩-550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com

EUROPE IVD MARKET

Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/europe-ivd-market

Follow Us On